Gilead Sciences (GILD) shares fell 2.6% in afternoon trading on Tuesday after Leerink Partners downgraded the company's stock to market perform from outperform and adjusted the price target to $127 From $146.
Trading volume stood at more than 4.3 million shares against a daily average of about 7.5 million.
Price: $129.79, Change: $-3.42, Percent Change: -2.57%
